Recurrent stroke predictors differ in medically treated patients with pathogenic vs other PFOs

Neurology

Volumn 83, Issue 3, 2014, Pages 221-226

  Thaler, David E ^a   Ruthazer, Robin ^a   Weimar, Christian ^b   Mas, Jean Louis ^c   Serena, Joaquín ^d   Di Angelantonio, Emanuele ^e   Papetti, Federica ^f   Homma, Shunichi ^g   Mattle, Heinrich P ^h   Nedeltchev, Krassen ⁱ   Mono, Marie Luise ^h   Jaigobin, Cheryl ^j   Michel, Patrik ^k   Elkind, Mitchell S V ^g   Di Tullio, Marco R ^g   Lutz, Jennifer S ^a   Griffith, John ^a   Kent, David M ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c CENTRE HOSPITALIER SAINTE ANNE   (France)

^d GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g Och Spine at New York Presbyterian Hospitals   (United States)

^h UNIVERSITY OF BERN   (Switzerland)

ⁱ Triemli Municipal Hospital   (Switzerland)

^j UNIVERSITY OF TORONTO   (Canada)

^k LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; COMORBIDITY; DATABASES, FACTUAL; EMBOLISM, PARADOXICAL; FEMALE; FOLLOW-UP STUDIES; FORAMEN OVALE, PATENT; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RISK ASSESSMENT; STROKE;

EID: 84905817688     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000589     Document Type: Article

References (14)

1. Carroll JD, Saver JL, Thaler DE, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 2013;368:1092-1100.
2. Meier B, Kalesan B, Mattle HP, et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 2013;368:1083-1091.
3. Furlan AJ, Reisman M, Massaro J, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 2012;366:991-999.
4. Kent DM, Ruthazer R, Weimar C, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology 2013;81:619-625.
5. Thaler DE, Di Angelantonio E, Di Tullio MR, et al. The Risk of Paradoxical Embolism (RoPE) Study: initial description of the completed database. Int J Stroke 2013; 8:612-619.
6. Thaler DE, Ruthazer R, Di Angelantonio E, et al. Neuroimaging findings in cryptogenic stroke patients with and without patent foramen ovale. Stroke 2013;44: 675-680.
7. Kent DM, Thaler DE. The Risk of Paradoxical Embolism (RoPE) Study: developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic stroke. Trials 2011;12:185.
8. Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl JMed 2001;345:1740-1746.
9. Johnston SC, Leira EC, Hansen MD, Adams HP Jr. Early recovery after cerebral ischemia risk of subsequent neurological deterioration. Ann Neurol 2003;54:439-444.
10. Johansson MC, Eriksson P, Guron CW, Dellborg M. Pitfalls in diagnosing PFO: characteristics of false-negative contrast injections during transesophageal echocardiography in patients with patent foramen ovales. J Am Soc Echocardiogr 2010;23:1136-1142.
11. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002;105:2625-2631.
12. Messe SR, Silverman IE, Kizer JR, et al. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004;62:1042-1050.
13. Wu LA, Malouf JF, Dearani JA, et al. Patent foramen ovale in cryptogenic stroke: current understanding and management options. Arch Intern Med 2004;164:950-956.
14. Pristipino C, Anzola GP, Ballerini L, et al. Management of patients with patent foramen ovale and cryptogenic stroke: a collaborative, multidisciplinary, position paper. Catheter Cardiovasc Interv 2013;82:E38-E51..